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MiRP2 Forms Potassium Channels in Skeletal Muscle
with Kv3.4 and Is Associated with Periodic Paralysis
Here, the function and disease association of the
KCNE3-encoded peptide MiRP2 is demonstrated.
Because KCNE3 transcripts are expressed abun-
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dantly in human skeletal muscle, we sought to evaluate*Departments of Pediatrics and Cellular
a well-recognized but unexplained discrepancy: despiteand Molecular Physiology
the presence of three channel subunits that form de-Boyer Center for Molecular Medicine
polarization-activated, rapidly inactivating (A-type) po-Yale University School of Medicine
tassium channels when the clones are studied in ex-New Haven, Connecticut 06536
perimental cells, no such currents are observed in†University of Utah
mammalian skeletal muscle cells (Adrian et al., 1970;Howard Hughes Medical Institute
Beam and Donaldson, 1983). While Kv1.4 and Kv4.1Salt Lake City, Utah 84112
might have eluded detection because the first is ex-‡National Institute of Neurologic Diseases and Stroke
pressed only at low levels and the latter only early inNational Institutes of Health
development, Kv3.4 transcript and protein are ex-Bethesda, Maryland 20892
pressed predominantly and robustly in skeletal muscle
throughout life (Lesage et al., 1992; Rettig et al., 1992;
Weiser et al., 1994; Veh et al., 1995; Vullhorst et al.,
Summary 1998). More puzzling, cloned Kv3.4 channels are also
characterized by activation at suprathreshold poten-
The subthreshold, voltage-gated potassium channel tials, slow recovery from rapid inactivation, and slow
of skeletal muscle is shown to contain MinK-related recovery from inactivation (producing afterhyperpolar-
peptide 2 (MiRP2) and the pore-forming subunit Kv3.4. ization, AHP) (Ruppersberg et al., 1991a), and these attri-
MiRP2-Kv3.4 channels differ from Kv3.4 channels in butes are not manifest in muscle recordings (Vazquez,
unitary conductance, voltage-dependent activation, 1988; Schroter et al., 1991; Rizzo and Nonner, 1992;
recovery from inactivation, steady-state open proba- Camacho et al., 1996). These findings argue that Kv3.4
bility, and block by a peptide toxin. Thus, MiRP2-Kv3.4 displays different attributes in experimental and native
channels set resting membrane potential (RMP) and cells, perhaps due to the influence of an unrecognized
do not produce afterhyperpolarization or cumulative channel subunit. Indeed, a role for a small protein is
inactivation to limit action potential frequency. A mis- suggested by the observation that small messenger
sense mutation is identified in the gene for MiRP2 RNAs from brain can alter A-type channel gating (Rudy
(KCNE3) in two families with periodic paralysis and et al., 1988; Chabala et al., 1993). For these reasons,
found to segregate with the disease. Mutant MiRP2- we tested the hypothesis that MiRP2 was necessary
Kv3.4 complexes exhibit reduced current density and to generate native skeletal muscle currents with Kv1.4,
diminished capacity to set RMP. Thus, MiRP2 operates Kv4.1, or Kv3.4.
with a classical potassium channel subunit to govern We demonstrate here that MiRP2 has no apparent
skeletal muscle function and pathophysiology. effect on Kv1.4 or Kv4.1, but forms stable complexes
with Kv3.4 subunits to alter their single-channel conduc-
tance, open probability, and sensitivity to a peptideIntroduction
toxin. Moreover, MiRP2-Kv3.4 channels are demon-
strated to have the same attributes as native channels
The KCNE genes encode small, single transmembrane-
studied in the plasma membranes of C2C12 skeletal
domain peptides that associate with pore-forming po-
muscle cells (where MiRP2 and Kv3.4 are shown to local-
tassium channel subunits to form mixed complexes with ize). Compared to Kv3.4, native MiRP2-Kv3.4 channels
unique characteristics (Abbott and Goldstein, 1998). The pass more potassium ions due to their larger unitary
peptides do not function alone. KCNE1 and 2 peptides conductance, faster recovery from inactivation, and
are abundant in the heart where they contribute to re- slower cumulative inactivation. Because MiRP2-Kv3.4
polarizing channels that are required for normal cardiac channels are 80-fold more active at -40 mV, they estab-
electrical function. Thus, MinK (encoded by KCNE1) as- lish the resting membrane potential (RMP) of C2C12
sembles with KCNQ1 to form IKs channels (Barhanin et muscle cells. Due to their rapid recovery from inactiva-
al., 1996; Sanguinetti et al., 1996), MiRP1 (MinK-related tion, MiRP2-Kv3.4 channels do not show AHP-associ-
peptide 1 from KCNE2) combines with HERG to form IKr ated reopenings during post-stimulus recovery as do
channels (Abbott et al., 1999), and mutations of KCNE1 cloned Kv3.4 channels.
(Splawski et al., 1997; Sesti and Goldstein, 1998) and Based on these observations (and prior association of
KCNE2 (Abbott et al., 1999; Sesti et al., 2000) are associ- KCNE1 and 2 with cardiac arrhythmia), we hypothesized
ated with life-threatening cardiac arrhythmia. Five KCNE that mutations in KCNE3 might be associated with inher-
genes are now known: KCNE1 (Takumi et al., 1988), 2, ited disorders of skeletal muscle. Screening has identi-
3, 4 (Abbott et al., 1999), and 5 (Piccini et al., 1999). fied two families in which a missense point mutation
encoding R83H-MiRP2 segregates with symptoms and
electromyographic abnormalities of periodic paralysis.§ To whom correspondence should be addressed (e-mail: steve.
goldstein@yale.edu). The mutant MiRP2 is found to form complexes with
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Kv3.4 that are abnormal in function, passing less out- hamster ovary (CHO) cells and to evaluate native expres-
sion of the subunits in adult rat skeletal muscle tissueward current upon activation and demonstrating a di-
minished capacity to set resting potential compared to and a murine skeletal muscle cell line (C2C12). Expres-
sion of MiRP2 in CHO cells allowed detection of fourwild type. Supporting a direct role in muscle dysfunction,
the mutant suppresses wild-type MiRP2-Kv3.4 channel bands with apparent molecular masses between 14 and
21 kDa after SDS-PAGE separation and visualizationcurrents in experimental cells and shifts resting potential
to abnormally depolarized voltages when it is expressed with polyclonal rabbit anti-MiRP2 antibodies (Figure 1C,
lane 2). As expected for a peptide with three N-linkedin skeletal muscle cells. This report explains differences
between cloned Kv3.4 channels and native muscle cur- glycosylation sites, treatment with endoglycosidase F
collapsed the four bands to one at the predicted massrents, establishes a requirement for wild-type MiRP2
in normal skeletal muscle function, and expands the of MiRP2 bearing no complex carbohydrate (z14 kDa,
Figure 1C, lane 3). The bands were not detected in un-recognized roles of the KCNE-encoded MinK-related
subunits by demonstrating that they are not limited to transfected cells (Figure 1C, lane 1) or in cells expressing
MiRP2 but probed with preimmune serum (not shown).channels formed with KCNQ and HERG class subunits,
but assemble with classical voltage-gated potassium Adult rat sartorius muscle tissue showed the same spe-
cific bands for MiRP2, with immature forms becoming(Kv) channel subunits to determine their behavior as
well. visible after overexposure (Figure 1D, lanes 1 and 2).
Analysis of C2C12 muscle cells also revealed MiRP2-
specific bands between 14 and 21 kDa, with the fullyResults
glycosylated form most abundant (Figure 1E, lane 1);
again, endoglycosidase F collapsed the bands to a sin-KCNE3 Is Located on Chromosome 11q,
gle species at z14 kDa (not shown).Expressed in Skeletal Muscle, and Predicts
Expression of Kv3.4 in CHO cells and study of rata 103 Residue Peptide
sartorius muscle allowed detection of specific bands atWith a search strategy based on residues critical for
z66 and 97 kDa with commercial anti-Kv3.4 antibodiesKCNE1 (MinK) function in cardiac IKs channels, we pre-
(Figure 1C, lane 5 and Figure 1D, lane 4). The presenceviously cloned KCNE2, 3, and 4 (encoding MiRP1, 2 and
of Kv3.4 protein in C2C12 muscle cells was confirmed by3) and localized human KCNE1 and 2 to chromosome
detection of a specific 66 kDa band (Figure 1E, lane 3).21q22.1 (Abbott and Goldstein, 1998; Abbott et al.,
Immunofluorescent staining revealed that native1999). KCNE5 (encoding MiRP4) was identified by others
MiRP2 and Kv3.4 subunits were both present in theon a segment of the X chromosome deleted in AMME
plasma membranes of C2C12 muscle cells. Thus, MiRP2syndrome (Piccini et al., 1999).
and Kv3.4 antibodies demonstrated specific punctateHere, we first localized KCNE3 to 11q13–14 by radia-
plasma membrane accumulations (Figure 1F, panels 1tion hybrid mapping. Thereafter, human tissues were
and 3, respectively). Moreover, MiRP2 and Kv3.4 sub-assessed by Northern blotting using a 1 kb fragment of
units formed detergent-stable complexes when co-human KCNE3, revealing an abundant single message
expressed in the mammalian cell line COS. Thus, spe-only in skeletal muscle among 16 tissues tested (Figure
cific MiRP2 bands were detected between 14 and 211A; day 1); after extended exposure, transcripts were
kDa in whole cell lysates (Figure 1G, lane 1) and afteralso apparent in samples from heart and brain (not
immunoprecipitation with anti-Kv3.4 (Figure 1G, lane 3).shown, day 10). The same expression pattern was ob-
tained using a 133 bp fragment from the 39UTR of KCNE3
as a probe (Experimental Procedures). Multiple identical MiRP2-Kv3.4 Complexes Show Altered
clones of KCNE3 were then isolated from human skeletal Voltage-Dependent Activation
muscle, heart, and brain as previously described (Abbott and Single-Channel Current
et al., 1999). A predicted open reading frame of 309 bp MiRP2 had no significant effect on either Kv1.4 or
forecasts a peptide of 103 residues with three N-linked Kv4.1 (Experimental Procedures). Conversely, Kv3.4 and
glycosylation sites, a single transmembrane (TM) do- MiRP2-Kv3.4 channels displayed marked differences in
main, and one consensus sequence for protein kinase voltage-dependent activation that were apparent in both
C-mediated phosphorylation. Alignment of human MiRP2 macroscopic and single-channel current recordings
and MinK (which has 129 residues) using ClustalW1.6, (Figures 2A and 2D). While Kv3.4 channels passed only
as before (Abbott et al., 1999), yields two gaps, 22% outward currents when expressed in CHO cells and
identity and 39% homology. These attributes suggest studied in large cell-attached patches with roughly equal
that MiRP2 has a Type I membrane topology (external potassium levels on either side of the membrane,
N terminus, a single TM domain, and an internal C termi- MiRP2-Kv3.4 channels passed both inward and outward
nus) like other KCNE subunits (Abbott and Goldstein, currents (Figures 2A and 2B). This can be understood
1998) (Figure 1B); in contrast, a 6 TM topology is typical from the normalized conductance-voltage relationships
for pore-forming a subunits of voltage-gated potassium for the two channel types (Figure 2C): channels with
channels like Kv3.4 (Figure 1B). MiRP2 achieved half-maximal activation at 243.8 6 1.4
mV while homomeric Kv3.4 channels required signifi-
cantly greater depolarization (V1/2 5 13.3 6 1.9 mV). ThisMiRP2 and Kv3.4 Subunits Localize in Skeletal
Muscle Plasma Membranes and Form difference was also apparent at the single-channel level
where MiRP2-Kv3.4 but not Kv3.4 channels exhibitedStable Complexes
Western blot analysis was used to study MiRP2 and significant numbers of openings with voltage steps to
hyperpolarized potentials (Figure 2D).Kv3.4 subunits expressed heterologously in Chinese
MiRP2: Channels in Muscle and Periodic Paralysis
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Figure 1. MiRP2 and Kv3.4 Subunits Localize
to Skeletal Muscle Plasma Membrane and
Form Stable Complexes
(A) Tissue distribution of human KCNE3 en-
coding MiRP2. Northern blot of indicated hu-
man tissues performed with a 1 kb KCNE3
fragment (upper panel) and a b-actin probe
(lower panel).
(B) Predicted topology of MiRP2 and Kv3.4
channel subunits; P, pore loop domain.
(C) Western blot analysis of CHO cell lysates
probed with anti-MiRP2 (lanes 1–3) or anti-
Kv3.4 antibodies (lanes 4 and 5). Cells were
treated with plasmids containing the genes
for: lane 1: untransfected; lane 2: MiRP2; lane
3: MiRP2 (sample treated with endoglycosi-
dase F); lane 4: untransfected; lane 5: Kv3.4.
Arrows correspond to apparent molecular
weights: lanes 1–3: upper, 21 kDa; lower, 14.5
kDa; lanes 4, 5: upper, 97 kDa; lower, 66 kDa.
(D) Western blot analysis of rat sartorius mus-
cle. Lane 1: probed with anti-MiRP2; lane 2:
probed with anti-MiRP2, extended exposure;
lane 3: probed with preimmune serum (nega-
tive control); lane 4: probed with anti-Kv3.4;
lane 5: probed with anti-Kv3.4 after pretreat-
ment with Kv3.4 peptide (negative control).
Arrows correspond to apparent molecular
weights: lanes 1–3: upper, 21 kDa; lower, 14.5
kDa; lanes 4 and 5: upper, 97 kDa; lower,
66 kDa.
(E) Western blot analysis of C2C12 muscle
cell lysates. Lane 1: probed with anti-MiRP2;
lane 2: probed with preimmune serum (nega-
tive control); lane 3: probed with anti-Kv3.4;
lane 4: probed with anti-Kv3.4 after pretreat-
ment with Kv3.4 peptide (negative control).
Arrows correspond to apparent molecular
weights: lanes 1 and 2: upper, 21 kDa; lower,
14.5 kDa; lanes 3, 4: upper, 97 kDa; lower,
66 kDa.
(F) Surface immunostaining of C2C12 muscle
cells. Panels indicate C2C12 cells incubated
with (1) anti-MiRP2 antibody; (2) preimmune
serum; (3) anti-Kv3.4 antibody; (4) without pri-
mary antibody.
(G) Coimmunoprecipitation. Lanes contain lysates of COS cells expressing both HA-tagged MiRP2 and Kv3.4 subunits and were probed with
anti-HA antibody; (1) total lysate; (2) after IP with control antiserum; (3) after IP with anti-Kv3.4. Arrows: upper, 21 kDa; lower, 14.5 kDa.
Another effect of MiRP2 was to increase the amplitude tained any other channels (Experimental Procedures).
The native channel was like MiRP2-Kv3.4 channels inof single-channel currents. Thus, Kv3.4 channels had
smaller unitary currents than MiRP2-Kv3.4 complexes CHO cells in that it passed potassium (Figure 3A), was
opened by depolarization with a subthreshold midpointdue primarily to voltage-dependent current rectification
(Figures 2E and 2F). The slope conductance from 10–50 activation voltage (Figures 3A and 3B), was inactivating
(Figure 3B), and had the same unitary current amplitudemV was 21 6 0.9 pS for Kv3.4 channels while it was
26 6 0.5 pS for MiRP2-Kv3.4 complexes; (unitary cur- and rectification behavior (Figure 3C), similar steady-
state open probability (Figure 4A), similar open staterents at 160 mV were 1.6 6 0.1 and 2.0 6 0.1 pA for
Kv3.4 and MiRP2-Kv3.4 channels, respectively). dwell times (Figure 4B), and identical sensitivity to a
peptide toxin (Figure 5).
Thus, both channels passed potassium and were acti-C2C12 Skeletal Muscle Cells Express a Native
Channel with Biophysical and Pharmacological vated by steps to negative voltages where Kv3.4 chan-
nels are silent (Figures 2D and 3A). The native channelCharacteristics of MiRP2-Kv3.4 Complexes
As C2C12 muscle cells display both MiRP2 and Kv3.4 on displayed a single-channel current amplitude of 2.1 6
0.1 pA at 160 mV and a slope conductance of 31 6 0.4their surface (Figure 1F), cell-attached patch recordings
were performed (Figure 3). These studies revealed a pS between 110 and 150 mV (Figures 3A and 3C) similar
to values observed for MiRP2-Kv3.4 complexes (but notnative potassium channel like MiRP2-Kv3.4 and dissimi-
lar to Kv3.4 in z20% of patches (n z250 cell-attached Kv3.4 channels) in CHO cells (Figures 2D–2F). When
single native channels were stepped repetitively frompatches studied). To quantify the attributes of this native
channel, patches were discarded (z50%) if they con- 280 to 160 mV, they activated rapidly with an apparent
Cell
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Figure 2. MiRP2-Kv3.4 Channels Activate More Readily and Have a Larger Unitary Conductance than Kv3.4 Channels
Studies of Kv3.4 channels (solid squares) and hMiRP2-Kv3.4 complexes (open squares) were performed in CHO cells in on-cell patch
configuration with 100 mM KCl solution in bath and pipette using Protocol 1 (A–D) and Protocol 2 (E and F) (Experimental Procedures). Data
were collected at 5 kHz, digitally filtered at 1 kHz or 500 Hz. Error bars represent SEM.
(A) Representative current families between 2100 and 60 mV in patches with high channel density (inset, Protocol 1); scale bars 50 pA and
500 ms, dashed line represents zero current level.
(B) Normalized peak current voltage relationship for recordings as in (A) (n 5 16–19 patches).
(C) Normalized conductance-voltage relationship for patches in (B). Curves were fit to a Boltzmann function: 1/{1 1 exp[(V1/22V)/Vs]}, where
V1/2 is the half-maximal voltage of activation and Vs the slope factor. Kv3.4 channels showed: V1/2 5 3.3 6 1.9 mV, Vs 5 24.5 6 1.6 mV; MiRP2-
Kv3.4 channels showed: V1/2 5 243.8 6 1.4 mV, Vs 5 12.4 6 1.3 mV.
(D) Representative current families between 280 mV and 80 mV in patches containing z5 channels, scale bars 2 pA and 1 s.
(E) Representative all-points histograms computed at 60 mV; does not reflect open probability.
(F) Current-voltage relationships for single Kv3.4 or MiRP2-Kv3.4 channels in cell-attached patches (n 5 4–6) studied at the indicated voltages.
All-points histograms constructed with .2 3 105 events (.500 transitions) per voltage per patch.
mean first latency of z45 ms (Figure 3B). Fifty consecu- fit by a sum of two exponential terms with time constants
of 1.80 6 0.03 and 21.0 6 0.1 ms and 1.6 6 0.2 andtive pulses showed ten null records and an ensemble
with kinetics like those of MiRP2-Kv3.4 complexes in 15.5 6 0.1 ms, respectively (Figure 4B, lower panels,
n 5 4–5 patches).CHO cells (Figures 2A and 3B).
While cloned Kv3.4 channels were not activated at MiRP2-Kv3.4 and native channels also showed similar
inhibition by the peptide toxin blood-depressing sub-potentials negative to 220 mV, as expected (Schroter
et al., 1991), MiRP2-Kv3.4 complexes in CHO cells and stance 2 (BDS-II) (Figure 5). This naturally occurring pep-
tide from the sea anemone Anemonia sulcata blocksnative channels in C2C12 cells showed both activation
and a significant steady-state open probability (Po) at cloned Kv3.4 channels in the nanomolar range but has
negligible effects on other channels in the Kv and Kirhyperpolarized potentials. This was quantified for single
channels in on-cell patches held at 240 mV for 5–10 families that were tested (Diochot et al., 1998). To study
steady-state blockade, BDS-II was applied to the exter-min (Figure 4). Whereas Kv3.4 channels opened rarely
and briefly, MiRP2-Kv3.4 and native channels opened nal face of single channels in outside-out patches held
at 240 mV. Current inhibition was found to be reversiblefrequently and for longer duration (Figure 4A). All-points
histograms reported a Po of 0.0005 6 0.0003 for Kv3.4 (not shown) and was observed as a reduction in single-
channel open probability for Kv3.4, MiRP2-Kv3.4, andchannels whereas MiRP2-Kv3.4 and native channels
were open 80- to 100-fold more often with Po values of native channels (Figure 5A). Dose inhibition relationships
for the three channels were constructed using all-points0.04 6 0.01 and 0.05 6 0.02, respectively (Figure 4B,
upper panels, n 5 4–5 patches). While Kv3.4 channel histograms to quantify relative open probability at vari-
ous toxin concentrations (Figures 5B and 5C). Whileopenings were short-lived with dwell times that were
best fit to a single exponential (t 5 2.6 6 0.06 ms), both Kv3.4 channels demonstrated a half-blocking concen-
tration (Ki) of 0.26 6 0.06 mM (n 5 4 patches), MiRP2-MiRP2-Kv3.4 and native channel open times were best
MiRP2: Channels in Muscle and Periodic Paralysis
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Kv3.4 and native channels in C2C12 cells were z30-
fold less sensitive with Ki values of 7.2 6 1.8 and of
6.9 6 2.7 mM, respectively (n 5 3–4 patches).
MiRP2-Kv3.4-Like Channels in C2C12 Muscle
Cells Set Resting Membrane Potential (RMP)
Their activity at negative potentials suggested that
MiRP2-Kv3.4 and native channels should influence rest-
ing membrane potential while Kv3.4 channels might not.
To test this hypothesis, whole-cell current clamp was
performed with a nystatin-perforated patch technique
with physiological levels of bath potassium (4 mM) (Fig-
ure 6). CHO cells expressing Kv3.4 had a mean resting
membrane potential (RMP) of 244 6 3 mV (n 5 11)
similar to that for mock-transfected cells (not shown).
Conversely, CHO cells expressing MiRP2-Kv3.4 chan-
nels had a RMP of 261 6 4 mV (n 5 8). To determine
the contribution of the channels to resting potential,
BDS-II was added at a level sufficient to completely
inhibit both Kv3.4 or MiRP2-Kv3.4 channels (30 mM).
Application of BDS-II to cells expressing Kv3.4 channels
did not significantly shift RMP (243 6 4 mV, n 5 7)
supporting the idea that these channels did not influence
resting potential. In contrast, toxin applied to CHO cells
expressing MiRP2-Kv3.4 channels produced a shift of
z20 mV in RMP to 243 6 1 mV (n 5 5). Native MiRP2-
Kv3.4-like channels in C2C12 cells were found to exert
similar control over resting potential. Thus, C2C12 cells
had an RMP of 265 6 4 mV (n 5 9) under control condi-
tions and showed a shift of z20 mV to 246 6 2 mV (n 5
4) with application of 30 mM BDS-II.
MiRP2-Kv3.4 channels influence RMP not only be-
cause they activate at hyperpolarized potentials (Figure
2C), but because they continue to pass outward potas-
sium current at steady state; this is apparent at both
the single-channel (Figure 4B) and macroscopic levels
(Figure 6B). Thus, the macroscopic Kv3.4 “window” con-
ductance (derived from steady-state, voltage-depen-
dent inactivation and activation relationships) had a
peak above 0 mV and was small below threshold (Figure
6C, upper) while the “window” for MiRP2-Kv3.4 was
maximal at 240 mV and of significant magnitude at
subthreshold potentials (Figure 6C, lower).
MiRP2 Alters Rate of Recovery from Inactivation
and Cumulative Inactivation
Cloned Kv3.4 channels show “fast” or A-type inactiva-
tion with maintained depolarization due to occlusion of
cell patch mode with 100 mM KCl in bath and pipette. Data were
collected at 5 kHz, digitally filtered at 1 kHz or 500 Hz.
(A) Representative openings between 240 mV and 80 mV in a patch
with z5 channels by Protocol 1; scale bars 2 pA and 100 ms.
(B) Voltage activation of single native C2C12 channels. (Top Panel)
Six representative traces during repetitive pulsing to 60 mV from a
holding voltage of 280 mV (inset, voltage Protocol 2); expanded
record for a trace with an apparent first latency of z40 ms (Experi-
mental Procedures). (Bottom panel) Ensemble average of 50 con-
secutive pulses to 60 mV. Scale bars 2 pA (top panel), 0.5 pA (bottom
panel), and 500 ms.
(C) Current-voltage relationships for single native C2C12 channels
in cell-attached patches (n 5 3–6) at the indicated voltages (Protocol
1). Error bars are SEM. All-points histograms constructed with .5 3
Figure 3. Native MiRP2-Kv3.4-Like Channels Are Observed in a 103 events (.10 transitions) per voltage per patch. C2C12 channels
Skeletal Muscle Cell Line (circles, thick line); Kv3.4 channels in CHO cells (thin line); MiRP2-
Studies of native channels were performed with C2C12 cells in on- Kv3.4 channels in CHO cells (dashed line).
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Figure 4. MiRP2-Kv3.4 and Native C2C12 Channels Have a Higher Steady-State Po than Kv3.4 Channels at Negative Potentials
Studies of single Kv3.4 or MiRP2-Kv3.4 channels expressed in CHO cells and native C2C12 cell channels were performed in cell-attached
patches at 240 mV (Protocol 3) with 100 mM KCl solution in the bath and pipette. Low-pass filtered at 500 Hz.
(A) Representative steady-state currents in patches containing one channel (cloned channels) or three channels (native C2C12 channels);
scale bars 2 pA and 500 ms. The displayed traces are 1 min continuous stretches of 5–10 min recordings at 6 s per line.
(B) (Upper panels) Representative all-points histograms computed from steady-state single-channel patches held at 240 mV for 5–10 min
and indicative of Po (cloned channels) or a three-channel patch indicative of nPo (native C2C12 channels). Left, Kv3.4 channels; central, MiRP2-
Kv3.4 channels; right, native C2C12 channels. (Lower panels) Representative dwell-time histograms computed at 240 mV from patches held
at steady state for 5–10 min. Left, Kv3.4 channels; central, MiRP2-Kv3.4 channels; right, native C2C12 channels. Dwell times were fit using
the Marquardt Least-Squares method (PSTAT). Kv3.4 channel dwell times were best fit with a single exponential, MiRP2-Kv3.4 and native
C2C12 channel with a double exponential function as indicated by thick lines; t values in text.
the internal pore by N-terminal “ball” residues (Ruppers- rapidly than Kv3.4 channels (Figure 7B). At the single-
channel level (in small cell-attached patches), Kv3.4berg et al., 1991b; Antz et al., 1997). Kv3.4 inactivation
rates vary widely with expression environment due to channels recovered slowly from inactivation showing
reopenings upon repolarization after stimulatory depo-kinase-mediated regulation (Covarrubias et al., 1994;
Diochot et al., 1998); conversely, recovery from inactiva- larization (Figure 7C), as previously described (Ruppers-
berg et al., 1991a). Conversely, recovery of MiRP2-Kv3.4tion is rapid in native cells (50–200 ms) (Rizzo and Non-
ner, 1992) but slow in experimental expression systems channels was rapid and reopenings could not be re-
solved despite the presence of similar numbers of chan-(0.5–1 s) (Ruppersberg et al., 1991a). When inactivation
is significant and recovery slow, reopening of channels nels in the patches (Figure 7C). Neither were reopenings
apparent in recordings of native MiRP2-Kv3.4-like singleupon repolarization produces afterhyperpolarization
(Ruppersberg et al., 1991b). It appears that MiRP2 un- channels in C2C12 muscle cells (Figure 3B) even with
recovery pulses lasting 10 s (not shown).derlies the rapidity of recovery from inactivation of native
channels and, thereby, suppression of afterhyperpolar- During repetitive stimulation (as in functioning mus-
cles and nerves), a balance between inactivation andization.
Recovery from inactivation was quantified first with recovery from inactivation determines the fraction of
voltage-gated ion channels that become unavailablewhole-cell currents using 3 s depolarizing pulses and
progressively longer recovery periods; the time course due to cumulative inactivation (Marom, 1998). Cumula-
tive inactivation was assessed here in on-cell patcheswas best fit with a double exponential function (Figure
7A). MiRP2-Kv3.4 complexes in CHO cells were found with alternating 1 s test pulses to 160 mV and 1 s in-
terpulse intervals at 280 mV (Figure 7D). As expected,to recover by 50% in z100 ms, at least 5-fold more
MiRP2: Channels in Muscle and Periodic Paralysis
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Figure 5. MiRP2-Kv3.4 and Native C2C12 Channels Have Similar Affinities for BDS-II Toxin
Studies of Kv3.4 channels (solid squares) or MiRP2-Kv3.4 channels (open squares) expressed in CHO cells or native C2C12 channels (gray
circles) performed in outside-out patches at 240 mV (Protocol 3) with 100 mM KCl solution in bath and pipette; toxin was applied in the bath
solution. Low-pass filtered at 500 Hz.
(A) Channel activity in various toxin concentrations as indicated; scale bars 1 pA and 1 s.
(B) Representative all-points histograms from patches at steady state for 5–10 min without toxin (control) or with 5 mM BDS-II and indicative
of nPo.
(C) BDS-II dose-inhibition curves for Kv3.4 channels (solid squares), hMiRP2-Kv3.4 channels (open squares), or native C2C12 channels (gray
circles), calculated using all-points histograms as in (B). Each point is the average of 2–3 patches and represents relative nPo normalized to
control nPo for that patch after toxin washout; error bars are SEM. Curves were fit to the function: y 5 [A1 2 A2 / {11(x/x0)p}] 1 A2 where X is
added toxin, xo the inhibition constant, and p the Hill coefficient. Kv3.4 channels: A1 5 1.00 6 0.03, A2 5 20.01 6 0.03, xo 5 255 6 63 nM,
p 5 0.7 6 0.1; MiRP2-Kv3.4 channels: A1 5 0.99 6 0.03, A2 5 20.002 6 0.04, xo 5 7148 6 1785 nM, p 5 0.97 6 0.27; native C2C12 channels:
A1 5 0.98 6 0.05, A2 5 20.02 6 0.05, xo 5 6886 6 2706 nM, p 5 0.79 6 0.2.
more than 50% of Kv3.4 channels were unavailable after morphism (SSCP) revealed an aberrant conformer in
two unrelated individuals (K2706 and K3337) from thejust two pulses while MiRP2-Kv3.4 complexes accumu-
lated in the inactive state at least 10-fold more slowly affected population with periodic paralysis. This variant
was not found in DNA from a control population of 120(Figure 7D).
unaffected individuals suggesting that it did not repre-
sent a polymorphism. DNA sequencing revealed aA Missense Mutation in Human MiRP2 Associated
with Periodic Paralysis G340A transition in the KCNE3 gene predicting an argi-
nine to histidine change at position 83 (R83H-MiRP2).Based on its expression in human skeletal muscle and
function in rodent skeletal muscle cells with Kv3.4, we Pedigree analysis of both kindreds revealed three addi-
tional family members with periodic paralysis who car-considered the gene for MiRP2 (KCNE3) a candidate for
heritable diseases of skeletal muscle that had not been ried the R83H mutation and two unaffected members
who did not (Figure 8A).genetically characterized. We therefore screened a
panel of 100 patients with inherited or sporadic episodic The proband in kindred 3337 is male and has had
episodes of paralytic weakness since he was 14 years ofmuscle disorders without mutations in known disease-
associated genes (SCN4A, CACNLA3, CLCN1) (Ptacek, age. Episodes are characterized by weakness primarily
affecting the lower extremities lasting hours to days. The1998). Analysis for single-strand conformational poly-
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Figure 6. MiRP2-Kv3.4 and Native C2C12
Channels Contribute to Resting Membrane
Potential
(A) Cells bathed in 4 mM KCl solution in the
absence (2) or the presence (1BDS) of 30
mM BDS-II toxin. After equilibration, resting
membrane potential (RMP) was measured in
current clamp mode using the nystatin perfo-
rated patch technique. Error bars indicate
SEM; asterisks denote measurements where
RMP was significantly different from toxin
blocked, as assessed by unpaired Student’s
t test; MiRP2-Kv3.4 channels, P 5 0.002; na-
tive C2C12 channels, P 5 0.005. Black bars,
CHO cells with Kv3.4 channels; open bars,
CHO cells with MiRP2-Kv3.4 channels; gray
bars, native C2C12 channels.
(B) Whole-cell steady-state currents re-
corded at 3 s with CHO cells expressing Kv3.4
alone (solid squares) or MiRP2-Kv3.4 (open
squares) in 4 mM KCl solution by protocol 1.
Error bars, SEM, n 5 8–10 cells.
(C) Steady-state inactivation and activation
voltage relationships determined from on-cell
macropatches with 100 mM KCl solution in
the pipette using CHO cells expressing Kv3.4
alone (upper panel) or MiRP2-Kv3.4 channels
(lower panel) by protocol 1. Inactivation
(squares): steady-state current divided by
peak current at each voltage. Activation (cir-
cles): G/Gmax is peak conductance normalized
to mean maximal MiRP2-Kv3.4 conductance.
Peak “window” conductances are indicated
by dashed lines. Conductance below –40 mV
is shaded. Error bars indicate SEM, n 5 16–19
patches.
attacks are usually precipitated by strenuous exercise ness and is not treated. All three of the living affected
individuals carry the R83H mutation while an unaffectedfollowed by rest or after prolonged sitting. Some attacks
occur when he wakes in the morning, but many begin sister does not (Figure 8A). Taken together, these pa-
tients were classified as having hypokalemic periodicduring wakefulness. He has never noticed that high car-
bohydrate meals precipitate attacks. To the contrary, paralysis because of the typical age-of-onset, paralytic
attacks that most often occur after exercise, a low potas-alcohol intake appears to facilitate recovery from an
attack while potassium treatment does not. The patient sium level during a spontaneous attack, and the ability
to precipitate an attack with insulin and glucose on onehas not had symptoms of myotonia and none were de-
tected by clinical exam or electromyography (EMG); a occasion. Atypical for this diagnosis is that the second
provocative test was negative and that attacks morelid-lag was detected on a few occasions. The parents
were not known to be affected and are deceased. The often began during wakefulness.
The proband in kindred 2706 is a boy who presentedproband’s two brothers and nephew have had similar
attacks of weakness (Figure 8A). One brother had onset at 22 months with episodes of weakness. The weakness
affects his lower and upper extremities. Most episodesof symptoms at age 21 but was not examined and is
deceased. Muscle biopsy revealed vacuoles and tubular come on during sleep and are brief (1–2 hr) although
they occasionally last for days. High carbohydrate mealsaggregates in both the proband and his other brother,
a common finding in all forms of periodic paralysis. With help to resolve the attacks. At the time of presentation,
an EMG did not demonstrate any myotonia and subse-one episode, his serum potassium level was determined
to be low (2.1 mmol/l). Provocative testing with insulin quent conduction and EMG studies have not given evi-
dence for neuropathy or myopathy. Serum potassiumand glucose lowered serum potassium and induced
weakness on one occasion but not with a second test levels have been measured during attacks and were nor-
mal. Provocative testing with potassium has not beensome years later. Potassium loading failed to induce
weakness arguing against the diagnosis of hyperka- performed. Treatment with the carbonic anhydrase inhibi-
tor acetazolamide prevents attacks. The proband’s fatherlemic periodic paralysis (Ptacek, 1998). The proband
has had significant reduction in attack frequency and has muscle cramps in cold water and weakness after
exercise although to a less severe degree than his son.severity when treated with the carbonic anhydrase inhib-
itor dichlorphenamide, but has developed mild to mod- Unfortunately, the father has not been available for further
evaluation. The age-of-onset, frequent nature of attacks,erate fixed weakness of the lower extremities. The living
brother has very minimal fixed iliopsoas muscle weak- and improvement with carbohydrate loading are all consis-
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Figure 7. MiRP2 Speeds Recovery from In-
activation and Suppresses Cumulative Inacti-
vation
(A) Recovery from inactivation for Kv3.4 chan-
nels (solid squares) and MiRP2-Kv3.4 chan-
nels (open squares) assessed in whole-cell
mode with 4 mM KCl bath solution. (Inset)
Protocol 4, asterisk denotes variable recov-
ery phase. For clarity, only the first test pulse
is shown and some recovery pulses are omit-
ted. Dashed line is zero current level. Scale
bars 300 pA (Kv3.4), 550 pA (MiRP2-Kv3.4),
and 100 ms. Double exponential fits indi-
cated.
(B) Mean % recovery of inactivated current-
recovery time relationship for whole-cell cur-
rents as in (A) (n 5 3); error bars indicate
SEM. Recovery time course was best fit with
a double exponential function of the form: y 5
yo 1 A1ex/t1 1 A2ex/t2. Kv3.4 (solid squares):
t1 5 1.7 6 0.7 s, A1 5 0.6 6 0.2; t2 5 222 6
134 ms, A2 5 0.4 6 0.2; MiRP2-Kv3.4 (open
squares): t1 5 520 6 30 ms, A1 5 0.7 6 0.07;
t2 5 39 6 24 ms, A2 5 0.3 6 0.1.
(C) Representative low current density cell-
attached patch traces illustrating extent of
reopening during recovery from inactivation
(Protocol 5, inset). Traces were recorded with
100 mM KCl in pipette and bath during repeti-
tive pulses and are typical of those observed
(n 5 12–15 patches). Top panel, Kv3.4, bot-
tom panel, MiRP2-Kv3.4, as indicated.
(D) Cumulative inactivation in cell-attached
patches recorded with 100 mM KCl in pipette
and bath. Kv3.4, solid squares; MiRP2-Kv3.4,
open squares. Top panels: representative
traces in train of pulses (Protocol 6, inset).
Bottom panel: normalized current with repeti-
tive pulsing as in traces, error bars 5 SEM
(n 5 6–8 cells), the first 14 pulses are shown.
Cumulative inactivation was fit with a single
exponential for Kv3.4 (y 5 yo 1 Aex/t; t 5 3.0 6
0.3 pulses) while for MiRP2-Kv3.4 it could
only be fit with a double exponential function:
y 5 yo 1 A1ex/t1 1 A2ex/t2; t1 5 6 6 1 and t2 5
75 6 15 pulses, with weights of 0.6 and 0.4,
respectively).
tent with hyperkalemic periodic paralysis. However, fre- of wild-type and R83H-MiRP2 cDNA (an approximation
of the genotype of patients carrying one mutant MiRP2quent attacks upon wakening and absence of myotonia
are atypical for this diagnosis. Both affected individuals allele) showed the same low current density (17.8 6 3.0
pA/pF, n 5 8) suggesting that the mutant had a dominantwere found to carry the R83H-MiRP2 mutation. The pro-
band’s mother is asymptomatic and carries wild-type effect (Figure 8B).
To confirm that R83H-MiRP2 altered Kv3.4 functionKCNE3 genes. His sister was not available for evaluation.
by formation of MiRP2-Kv3.4 channel complexes, sensi-
tivity to BDS-II was evaluated as before (Figure 4). TheR83H-MiRP2 Reduces MiRP2-Kv3.4 Current
dose-inhibition relationship for mutant channels gaveDensity and Capacity to Set Muscle Cell RMP
an inhibition constant of 5.5 6 1.6 mM, almost the sameTo determine if the R83H mutation altered MiRP2-Kv3.4
as that for wild-type MiRP2 and z20-fold different thanchannel function, its effects on whole-cell peak current
that measured for cloned Kv3.4 channels (Figure 8C).amplitudes in CHO cells were first evaluated (Figure 8B);
Moreover, there was no evidence that R83H-MiRP2 in-Kv3.4 subunits were expressed with a plasmid control,
fluenced the function of sodium, calcium, or chloridewild-type MiRP2, or R83H-MIRP2 and studied in 4 mM
channels previously associated with periodic paralysisexternal potassium. Current density at 150 mV was
(Ptacek, 1999) as neither wild-type nor mutant MiRP227.2 6 8.3 pA/pF for Kv3.4 channels (n 5 8) and 46.0 6
subunits altered the attributes of SCN4A, CACNLA3, or6.1 pA/pF for wild-type MiRP2-Kv3.4 channels (n 5 11);
CLCN1 in experimental cells (not shown).the point mutant reduced current density to 17.1 6 4.2
pA/pF (n 5 10). Further, cells treated with equal amounts R83H-MiRP2 was also found to suppress the capacity
Cell
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Figure 9. R83H-MiRP2 Has Reduced Capacity to Set RMP with
Kv3.4 and Depolarizes C2C12 Muscle Cells
Resting membrane potential (RMP) of CHO cells expressing R83H-
MiRP2-Kv3.4 channels or C2C12 cells transfected with wild-type
(WT) or R83H-MiRP2 and studied by perforated patch technique as
in Figure 6. Cells were bathed in 4 mM KCl solution in the absence
(2) (n 5 12–14) or presence (1BDS) (n 5 6) of 30 mM BDS-II. Error
bars are SEM. Dashed lines indicate RMP values determined for
CHO cells expressing Kv3.4 or wild-type MiRP2-Kv3.4 channels as
reported in Figure 6. Single asterisk denotes RMP values signifi-
cantly different from wild-type (P 5 0.039, CHO cells) or native (P 5
0.011, C2C12).
of MiRP2-Kv3.4 complexes to set resting potential in
experimental cells. CHO cells expressing R83H-MiRP2-
Kv3.4 channels were found to have an RMP of 252 6
4 mV (n 5 9) by the nystatin perforated-patch technique
(Figure 9), a value between that determined for cells
expressing cloned Kv3.4 channels and those expressing
wild-type MiRP2-Kv3.4 channels (244 mV and 261 mV,
respectively, Figure 6A). As before, BDS-II blockade
shifted the RMP of cells expressing R83H-MiRP2-Kv3.4
channels to control levels (246 6 1 mV, n 5 6, Figure
9) suggesting that RMP was mediated by channels con-
taining Kv3.4. Channels with the mutant influenced RMP
despite lowered outward current density (while Kv3.4Figure 8. R83H-MiRP2 Is Associated with Familial Periodic Paraly-
sis and Reduced Current Density channels did not) because their steady-state open prob-
ability at subthreshold voltages was greater than for(A) Pedigree structure of two kindreds (K2706 and K3337) displaying
periodic paralysis. Open symbols represent unaffected individuals, channels without MiRP2 (not shown).
closed symbols patients with periodic paralysis. Genotypes as indi- R83H-MiRP2 was also found to disrupt the function
cated, N.D. 5 not determined. Squares indicate males, circles fe- of native skeletal muscle channels, leading to altered
males. Arrow denotes proband. Status unknown (?); deceased (/).
RMP. Thus, when MiRP2 was expressed in C2C12 mus-(B) Current density at 50 mV in whole-cell configuration with 4 mM
cle cells without added Kv3.4, the wild-type subunitKCl bath solution (Protocol 1) for CHO cells expressing Kv3.4 and
produced no significant change in RMP compared to(2) a plasmid control, (WT) wild-type MiRP2, (R83H) R83H-MiRP2,
or (WT1R83H) equal amounts of wild-type and R83H-MiRP2, as control cells (265 6 3 mV, n 5 10, Student’s t test, P 5
indicated (n 5 8–11). Error bars indicate SEM. Single asterisk de- 0.17) whereas R83H-MiRP2 depolarized the muscle cells
notes R83H-MiRP2 current density significantly different than wild- to 253 6 2 mV (the same RMP observed when R83H-
type MiRP2 (P 5 0.0014); double asterisk denotes R83H1WT is
MiRP2 and Kv3.4 were overexpressed together in CHOsignificantly different than wild-type (P 5 0.0025) but not R83H-
cells, Figure 9). The native channels appeared to containMiRP2, as assessed by unpaired Student’s t test.
Kv3.4 as BDS-II caused RMP in both cell types to rise(C) Inhibition constant (Ki) for BDS-II blockade of single Kv3.4,
MiRP2-Kv3.4, or R83H-MiRP2-Kv3.4 channel currents assessed in to the level of control cells (245 6 1 and 244 6 1 mV
outside-out patches at 240 mV (Protocol 3) from dose-inhibition for wild-type and R83H-MiRP2, respectively).
curves as in Figure 5. Error bars are SEM. Dose-response curves
were fit as in Figure 5. R83H-MiRP2-Kv3.4 channels: A1 5 0.99 6 Discussion0.04, A2 5 20.02 6 0.04, Xo 5 5540 6 1670 nM, p 5 0.78 6 0.2.
The KCNE genes encode MinK-related peptides, single
transmembrane subunits that are inactive on their own
MiRP2: Channels in Muscle and Periodic Paralysis
227
but essential in native channel complexes (Abbott and the lack of rapidly inactivating potassium currents in
mammalian skeletal muscle (Adrian et al., 1970; BeamGoldstein, 1998). Thus, MinK (from KCNE1) and MiRP1
(from KCNE2) have been shown to establish key func- and Donaldson, 1983; Camacho et al., 1996), despite
the robust expression of Kv3.4 in skeletal muscle (Figuretional attributes in assemblies with KCNQ1 and HERG-
type pore-forming subunits: voltage-dependence, gating 1) (Rettig et al., 1992; Vullhorst et al., 1998), may be
explained in part by its assembly with MiRP2, but alsokinetics, single-channel conductance, ion selectivity,
regulation, and pharmacology. Here, we demonstrate appears to reflect regulatory influences. Indeed, we find
that inactivation of both Kv3.4 and MiRP2-Kv3.4 chan-that MiRP2 (from KCNE3) alters the same attributes as
its predecessors, but does so in complexes with Kv3.4, nels is more rapid and less variable in Xenopus oocytes
than in CHO cells (not shown).a classical Shaw-type subunit. MiRP2 is associated with
periodic paralysis and assembles with Kv3.4 in skeletal
muscle to form subthreshold, voltage-gated channels A Potential Role in Skeletal Muscle
that establish RMP. The wide tissue distribution of the A role for Kv3.4 subunits in skeletal muscle function has
MiRPs combined with their capacity to interact with a been considered likely because of their high degree of
variety of pore-forming subunits broadens their poten- expression in the tissue (Rettig et al., 1992; Weiser et al.,
tial roles in vivo. 1994; Veh et al., 1995; Vullhorst et al., 1998). Previously, it
was suggested that Kv3.4 might modulate inward cal-
cium currents because cloned Kv3.4 channels open inMiRP2-Kv3.4 Channel Complexes Recapitulate
the voltage range where some calcium channels acti-Potassium Currents in Native Cells
vate, positive to the threshold for sodium channel activa-Cloned channel subunits studied in experimental cells
tion (Schroter et al., 1991). Further, Kv3.4 channels wereoften behave differently than the currents attributed to
suspected to play a role in the morphology of actiontheir native counterparts. In some cases, this is due to
potentials, but not in control of resting potential or thethe absence of channel subunits whether cytoplasmic
rise to threshold due to their activation at suprathreshold(Rettig et al., 1994; An et al., 2000) or membrane (San-
potentials. Finally, the channels were suggested to pro-guinetti et al., 1996; Abbott et al., 1999). This discrepancy
duce AHPs based on their slow recovery from inactiva-has been particularly notable among the A-type potas-
tion (Ruppersberg et al., 1991a). In contrast, our resultssium channels (Rizzo and Nonner, 1992; Chabala et al.,
argue that Kv3.4 channels assemble with MiRP2 in1993; Xu et al., 1996). Here, we demonstrate that MiRP2
skeletal muscle cells to produce native channels thatand Kv3.4 subunits are expressed in skeletal muscle
activate at subthreshold levels, recover rapidly from in-cells (Figure 1); that the biophysical and pharmacologi-
activation, and influence skeletal muscle function. More-cal attributes of MiRP2-Kv3.4 channels in CHO cells and
over, expression of wild-type MiRP2 in C2C12 musclenative channels in C2C12 cells are similar (Figures 2–5);
cells had no significant effect while the disease-associ-and, that a disease-associated MiRP2 variant can sup-
ated R83H-MiRP2 produced depolarization (Figure 9).press native channel function in C2C12 muscle cells
This supports a direct role for wild-type MiRP2 subunits(Figure 9). These observations argue strongly that
in establishing RMP and for the mutant in muscle dys-MiRP2 and Kv3.4 subunits assemble to form a sub-
function. We conclude that MiRP2-Kv3.4 channels mod-threshold A-type potassium channel in skeletal muscle.
ulate excitability through effects on RMP, rates of riseOur findings are also consistent with previous descrip-
to threshold, action potential duration, and recovery oftions of cloned Kv3.4 and native A-type channel cur-
sodium channels from inactivation without production ofrents. Rettig and colleagues (Rettig et al., 1992) found
AHPs or cumulative inactivation to limit responsiveness.the same amplitude and rectification properties for sin-
While MiRP2-Kv3.4 channels appear to be the primarygle Kv3.4 channel currents in cell-attached patches as
determinant of RMP in undifferentiated C2C12 cells (Fig-measured here (Figures 2 and 4). More significantly, mild
ures 6A and 9), their relative contribution in differentrectification, increased magnitude, and greater steady-
muscle types (in health and disease) remains to be as-state Po of single MiRP2-Kv3.4 channels (Figures 2 and
certained. Thus, many vertebrate muscle fibers have a4) and native C2C12 channels (Figures 3 and 4) are very
large resting chloride conductance (Bretag, 1987) thatlike those reported for native voltage-gated channels
is decreased in some forms of inherited and acquiredrecorded in vesicles from frog skeletal muscle (z2 pA
myotonia in association with RMP “instability” (Leh-at 40 mV, Po of z0.05 at –40 mV) (Vazquez, 1988; Cama-
mann-Horn and Jurkat-Rott, 1999).cho et al., 1996) and in normal and denervated murine
skeletal muscle fibers (z2 pA at 150 mV) (Escobar et
al., 1993). Further, mean open times for MiRP2-Kv3.4 Other Roles for MiRP2
This study was guided by the prominent expression ofand native C2C12 cell channels are best fit by a sum of
two terms, as previously found for frog skeletal muscle MiRP2 and Kv3.4 in skeletal muscle and directed toward
understanding recognized discrepancies between cloned(Vazquez, 1988), although the time constants at 240 mV
measured here (z2.0 ms and 20 ms) are much longer channels and native currents in that tissue. Other pore-
forming subunits also interact with MiRP2 when studiedthan those observed in frog muscle (0.07 ms and 0.37
ms). Inactivation rates of both cloned and native A-type in experimental cells. Thus, MiRP2 was recently demon-
strated to alter the function of both KCNQ1 and HERGchannels vary widely between cell types and even from
cell to cell in the same preparation. This is understood when expressed in oocytes and hypothesized to be im-
portant to electrolyte balance in the colon (Schroeder etin some cases to result from regulated phosphorylation
of N-terminal inactivation “ball” residues (Covarrubias al., 2000). HERG cRNA is not found in adult mammalian
skeletal muscle (London et al., 1997; Wymore et al.,et al., 1994; Antz et al., 1997; Beck et al., 1998). Thus,
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1997) although gene expression is subject to regulation The familial periodic paralyses are rare disorders clas-
sified by their clinical features such as age of onset,(Arcangeli et al., 1999). Conversely, transcripts for
KCNQ1 are present in adult human skeletal muscle, al- time of day, frequency of attacks, and measures that
can provoke attacks (e.g., response to altered serumbeit at lower levels than in heart and colon (Yang et
al., 1997), suggesting that MiRP2 could influence its potassium level or other dietary factors). Because the
disorders are clinically and genetically heterogeneous,function in vivo. KCNQ1 subunits do not appear to be
involved in the effects of MiRP2 we describe here; while the overlapping signs, symptoms, and responses to
therapy have complicated diagnosis. Identification ofBDS-II blocks single MiRP2-Kv3.4 channels in both CHO
and C2C12 cells and shifts RMP in both cell types, the the underlying genetic basis has led to a new classifica-
tion system based on the molecular defects that havetoxin had no measurable effect on cloned KCNQ1 or
MiRP2-KCNQ1 channels (Experimental Procedures). It been found (Ptacek, 1998). This new scheme has aided
clinicians in diagnosis of the periodic paralyses and al-remains feasible that other pore-forming subunits in
skeletal muscle may interact with MiRP2 if their spatial lowed implementation of a therapeutic trial of dichlor-
penamide with patients enrolled based on characteriza-and temporal expression patterns overlap. As we did
not detect MiRP2 in human colonic poly(A)1 mRNA (Fig- tion of their specific mutations. While such carbonic
anhydrase inhibitors are anecdotally beneficial in manyure 1A), and Schroeder and colleagues (2000) did not
demonstrate the presence of MiRP2 peptide or MiRP2- patients, one study has shown benefit in a blinded and
controlled fashion (Tawil et al., 2000). This was likelyKCNQ1-like currents in colon cells, the contention that
MiRP2 functions in that tissue requires further support. due, in part, to enrollment of a study cohort that was
relatively homogeneous at a molecular level. The associ-
ation of KCNE3 mutations with clinical presentationsA MiRP2 Mutation Associated
that are not characteristic of either classical hyper- orwith Periodic Paralysis
hypokalemic periodic paralysis emphasizes the clinicalAssociation of a potassium channel subunit (R83H-
complexity of these disorders and the need for diagnosisMiRP2) with periodic paralysis is novel but consistent
based on genotype. Increasingly, such classificationwith current thinking on the etiology of these disorders.
should improve our ability to diagnose and treat theseIn each case, paralysis is associated with an abnormally
patients.positive skeletal muscle resting membrane, disrupted
sodium channel inactivation, and altered excitability.
Experimental ProceduresWith mutant MiRP2-Kv3.4 channels, this appears to re-
sult from decreased outward potassium flux producing a Study Subjects and Mutational Analysis
more positive RMP and reduced repolarization capacity. The GenBank accession numbers for human and mouse MiRP2
The functional effects we observe and correlation of (KCNE3) are AF076531 and AF076532, respectively. Clinical studies
and sampling of family members were conducted after subjectsgenotype and phenotype in our patients support a caus-
signed a consent form approved by the Institutional Review Boardative role for R83H-MiRP2 in periodic paralysis. To rein-
of the University of Utah Health Sciences Medical Center. Genomicforce this conclusion and explore the basis for symptom-
DNA was isolated from peripheral blood leukocytes, amplified using
atic differences between individuals, additional patients PCR, and single-strand conformational polymorphism (SSCP) analy-
will be sought. sis performed (Orita et al., 1989). Oligonucleotide primer pairs used
Familial hyperkalemic periodic paralysis has been as- to amplify KCNE3 for SSCP were section I (nucleotides 48–267 of
accession number AF076531), forward primer: 59-GTTTGAGCTTsociated with mutants of the SCN4A voltage-gated so-
CTACCGAG-39; reverse primer: 59-TGTAGGAGTTGTCATCAC-39;dium channel (encoded on chromosome 17q) (Ptacek
section II (corresponding to nucleotides 212–482), forward primer:et al., 1991) that are too active either because they open
59-CAACCAGACTGAAGAGAG-39; reverse primer: 59-CAGTCCAC
at abnormally negative potentials (Cummins et al., 1993) AGCAGAGTTC-39. Amplification reactions were carried out and
or inactivate too slowly (Cannon and Strittmatter, 1993; samples analyzed as before (Ptacek et al., 1992). Abnormal conform-
Cummins and Sigworth, 1996). Both changes increase ers were eluted and re-amplified for sequencing by dye termination
chemistry. The presence of the R83H-MiRP2 mutation was con-inward sodium flux leading to membrane depolarization
firmed independently by PCR amplification of patient genomic DNAand impaired repolarization. Similarly, familial hypoka-
and sequencing (Ptacek et al., 1992).lemic periodic paralysis has been associated with inex-
citability and a skeletal muscle RMP more positive than Heterologous Expression
normal (Lehmann-Horn and Jurkat-Rott, 1999) due to The mutation was produced in wild-type human KCNE3 in pGA1 as
mutations in the gene for the L-type calcium channel before (Abbott et al., 1999). The gene for rat Kv3.4 (Accession num-
ber Q63734) was generously provided by B. Fakler (Tubingen). Forencoded on chromosome 1q31-q32 (Fontaine et al.,
studies in oocytes, cRNA was transcribed for MiRP2 and Kv3.41994; Ptacek et al., 1994) and the SCN4A sodium chan-
genes in pGA1 as before (Abbott et al., 1999). Transient transfectionnel (Bulman et al., 1999; Jurkat-Rott et al., 2000). So,
of CHO, COS, and C2C12 cells was achieved with lipid-based re-
too, barium toxicity, a rare but well-documented cause agents and a vector carrying the gene for green fluorescent protein
of acute periodic paralysis, reduces potassium efflux (GFP). MIRP2, Kv3.4, and GFP were expressed in pCI-neo-based
from muscle cells (due in part to potassium channel vectors (Promega).
blockade) leading to membrane depolarization and
Purification of Recombinant MIRP2 and Antibody Productionmuscle cells that are inexcitable (Layzer, 1982). Even
The coding region of mouse KCNE3 encoding MIRP2 was subclonedchloride channel mutations can cause transient weak-
into the bacterial expression vector, pGEX6P-1 (Amersham Phar-ness in a related muscle disorder (Ptacek, 1998). The
macia Biotech, Piscataway, NJ) and MIRP2 purified by solubilization
previous lack of recognition of potassium channel muta- with 1% (w/w) sarkosyl followed by 1.3% Triton X-100 and cleavage
tions in periodic paralysis has been conspicuous based from its GST fusion product with Prescission protease (Amersham
Pharmacia). MiRP2 was subjected to SDS-PAGE, visualized withon our knowledge of membrane physiology.
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coomasie blue, excised from the gel, and injected into rabbits (Po- conductance, and BDS-II sensitivity (not shown). MiRP2 is now un-
der study in oocytes with KCNQ1, which produces a “leak” channelcono Rabbit Farm, Canadensis, PA). Immunoglobulin was affinity
purified with Protein-A sepharose beads (Amersham Pharmacia) phenotype (Schroeder et al., 2000); 30 mM BDS-II had no apparent
effect on KCNQ1 or MiRP2-KCNQ1 currents in oocytes (not shown).and specific antibody purified with a MiRP2-loaded PVDF mem-
brane (Immobilon-P, Millipore Corporation, Bedford, MA). Affinity-
purified antibody was used in all experiments. Electrophysiology with CHO and C2C12 Cells
For detailed characterization, Kv3.4 and MiRP2-Kv3.4 channels
were assessed using Chinese hamster ovary (CHO) cells by wholeProtein Biochemistry
cell or patch clamp 1–3 days after transfection. C2C12 murine skele-Crude membrane fractions were prepared from freshly collected
tal muscle cells are derived from 129 ReJ mice (Yaffe and Saxel,rat sartorius skeletal muscle using a tissue disruptor. Complete
1977) and were allowed to grow to a semi-confluent state (2–5 days),Protease Inhibitor Cocktail (Roche, Indianapolis, IN) was included
split, replated, and allowed to grow 2–3 additional days prior toin all buffer solutions used for protein preparation. Muscle homoge-
recording. CHO and C2C12 cell recording was with an Axopatchnates (20 g) in 30 ml of 320 mM sucrose, 5 mM HEPES (pH 7.5) were
200A Amplifier (Axon Instruments, Foster CIty, CA), an IBM com-centrifuged (3K 3 g) and filtered through Miracloth (Calbiochem-
puter, and CLAMPEX software (Axon Instruments). Data analysisNovabiochem Corporation, San Diego, CA). After adding KCl to 0.5
was performed using CLAMPFIT, FETCHAN, PSTAT (Axon Instru-M, the homogenate was incubated on ice for 10 min and centrifuged
ments), and TAC software (Instrutech, Great Neck, NY). All experi-at 48K 3 g for 40 min and the pellet washed twice in 150 mM NaCl,
ments were performed at room temperature.10 mM HEPES (pH 7.5). The resulting pellet was solubilized in SDS-
Patches from C2C12 cells most frequently contained two or threePAGE loading buffer for Western blot analysis (100 mg/lane).
MiRP2-Kv3.4-like channels (,10% single-channel patches) and areCHO cells were harvested 24 hr after transfection, solubilized with
reported as nPo and “apparent first latency”; expression levels werePBS containing 1% CHAPS, 1% Triton X-100, 1% NP-40, 0.5% SDS
varied to achieve single-channel patches for CHO cell recordings.before centrifugation at 50K 3 g for 20 min. The supernatant was
used directly for Western blot analysis (100 mg/lane) or denatured
by boiling in 0.5% SDS prior to treatment with endoglycosidase F Protocols
(Roche, Indianapolis, IN) overnight at 378C (1 U per 100 mg protein) Holding voltage was 280 mV unless otherwise stated. (1) Peak and
in 0.5 M Tris (pH 8), 0.25% Triton X-100. C2C12 cells were harvested steady-state current; 3 s pulse from 2100 to 90 mV in 10 mV steps
by centrifugation 2–5 days after replating using PBS containing 10 with a 5 s interpulse interval. (2) Single voltage; repetitive 3 s pulses
mM EDTA and then resuspended in 150 mM NaCl, 10 mM HEPES to a single voltage as indicated with a 5 s interpulse interval. (3)
(pH 7.5), 2% Triton X-100, and 0.25% SDS. Western blot analysis Steady-state; holding at 240 mV for 5–20 min with no interpulse
was performed with 100 mg protein per lane. Endoglycosidase F interval. (4) Inactivation recovery; 3 s depolarizing pulse to 30 mV
treatment of C2C12 cell lysates was followed by precipitation with followed by 290 mV recovery pulses of increasing duration in 40
10% TCA. ms steps; interpulse interval 5 s. (5) Recovery (reopening); repetitive
Coimmunoprecipitation of MiRP2 and Kv3.4 in COS-7 cells was 1.5 s pulses to 60 mV with a 5 s interpulse interval. (6) Cumulative
similar to previous methods (Abbott et al., 1999) except that the inactivation; repetitive 1 s pulses to 60 mV with 1 s total interpulse
complex was isolated with a commercial polyclonal anti-Kv3.4 anti- interval.
body (Alomone Labs, Jerusalem, Israel) using 10 mg antibody with
1.5 mg total protein. Ionic Conditions
Pipette solution for CHO cells in on-cell mode was (in mM): 100 KCl,
0.7 MgCl2, 1 CaCl2, 10 HEPES (pH 7.4). CHO cell bath solution wasWestern and Northern Blot Analyses
Western blot analyses were performed as previously (Abbott et al., as in the pipette or 4 mM KCl, 96 mM NaCl instead of 100 mM KCl
for whole-cell recording. Cell-attached recordings with C2C12 cells1999) except for evaluation of MIRP2 where SDS was omitted from
the transfer buffer and the transfer was conducted at 75 volts for 1 were performed with a pipette solution (in mM): 100 KCl, 0.7 MgCl,
1 EGTA, 10 HEPES (pH 7.4) and no added calcium and bath solutionshr to enhance retention and detection of small proteins. Both MIRP2
and Kv3.4 antibodies were used at a dilution of 1:200 and anti-HA as above. For all outside-out recordings pipette and bath solution
was (in mM): 100 KCl, 0.7 MgCl, 1 EGTA, 10 HEPES (pH 7.4).at 1:1000. Proteins were detected using either HRP-conjugated anti-
rabbit or anti-mouse secondary antibodies (Sigma-Aldrich) and ECL
reagents (Pierce, Rockford, IL). BDS-II Studies
Northern blots were performed with 32P[ATP]-labeled probes Outside-out patches were held at 240 mV and toxin applied exter-
(Amersham Pharmacia), first with the 1060 bp fragment of human nally via the bath solution containing 0.1% BSA. To ensure rundown
KCNE3 contained on EST AA132718, then with b-actin cDNA; the did not introduce artifacts, open probability was assessed after
specific labeling was identical using a 133 bp portion of the KCNE3 toxin washout and the patch was discarded if channel activity did
39UTR (42–174), not shown. The membranes were purchased (Clon- not return to within 10% of baseline (,20% of patches). BDS-II
tech) and contained 2 mg poly(A)1 mRNA purified from 16 human applied in the pipette in on-cell patches (where rundown is not seen)
tissues. While a single strong message was observed in skeletal gave the same apparent affinity for both Kv3.4 and MiRP2-Kv3.4
muscle (and weak bands in heart and brain transcripts after ex- channels (n 5 3, not shown).
tended exposure), no message was visualized in ovary, testis, pros-
tate, thymus, spleen, or the other eight tissues shown in Figure 1A. Perforated Patch Technique
This was performed with nystatin (Sigma) at a final concentration
Surface Immunostaining of C2C12 Muscle Cells of 150 mg/ml in the pipette solution. After filling the tip with normal
48 hr after plating onto cover slips, C2C12 cells were incubated pipette solution, nystatin solution was used to back-fill. After seal
with primary antibody for 1 hr, washed, fixed with 4% paraformalde- formation, patches were held at 280 mV for 30 s, then resting mem-
hyde, and incubated with either CY3-conjugated goat anti-rabbit brane potential was measured in current-clamp configuration after
secondary antibody (for Kv3.4) or Oregon Green-conjugated goat attainment of whole-cell configuration as assessed by resistance
anti-rabbit secondary antibody (MiRP2 and negative control) for testing.
immunofluorescence microscopy.
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